Eutilex Competitors and Similar CompaniesClear all
Eutilex's competitors and similar companies include Neovii and ImmPACT-Bio.
 Eutilex Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology. |  Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
|  ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. | |
Founding Date | Founding Date 2015 | Founding Date 2003 | Founding Date 2017 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations KR HQ | Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US | Locations Camarillo, US HQ Rishon Le Tsiyon, IL |
Employees | Employees 141 | Employees 1193% increase | Employees 845% decrease |
Funding | |||
Total funding raised | Total funding raised $ 18.9m | Total funding raised N/A | Total funding raised $ 18m |
For sources of this data, please see the company profile
View Company Profiles
Neovii
HQ
Rapperswil-Jona, CH
Employees
119↑ 3% increase
Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
View companyImmPACT-Bio
HQ
Camarillo, US
Employees
84↓ 5% decrease
ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.
View company